The preclinical discovery and development of rectal artesunate for the treatment of malaria in young children: a review of the evidence

References

• World Health Organization. Guidelines for malaria treatment. 1st ed. Switzerland: World Health Organization; 2006.
   Google Scholar
• Severemalaria.org [Internet]. [ Cited 2019 Nov 23]. Available from: www.severemalaria.org› files › SmPC_RAS_Cipla
   Google Scholar
• Strides Pharma Science Limited. WHO-PQ recommended patient information leaflet. India; 2018. [cited 2019 Nov 24]. Available from: https://extranet.who.int/prequal/sites/default/files/MA123part3.pdf
   Google Scholar
• Medicines for Malaria Venture [Internet]. Artesunate rectal capsules. 2019 [cited 2019 Dec 17]. Available from: https://www.mmv.org/access/products-projects/rectal-artesunate-ras
   Google Scholar
• World Health Organization [internet]. Rectal artesunate for pre-referral treatment of severe malaria. 2017 [cited 2019 Nov 3]. Available from: https://www.who.int/malaria/publications/atoz/rectal-artesunate-severe-malaria/en/
   Google Scholar
• Phillips MA, Goldberg DE. Toward a chemical vaccine for malaria. Science. 2018;362:1112–1113.
   PubMed Web of Science ®Google Scholar
• World Health Organization [internet]. 2020 [cited 2020 May 13]. Available from: https://www.who.int/publications-detail/world-malaria-report-2019
   Google Scholar
• Mishra M, Mishra VK, Kashaw V, et al. Comprehensive review on various strategies for antimalarial drug discovery. Eur J Med Chem. 2017;125:1300–1320.
   PubMed Web of Science ®Google Scholar
• Trampuz A, Jereb M, Muzlovic I, et al. Clinical review: severe malaria. Crit Care. 2003;7(4):315–323.
   PubMed Web of Science ®Google Scholar
• Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. New Eng J Med. 1995;332(21):1399–1404.
   PubMed Web of Science ®Google Scholar
• Tse EG, Korsik M, Todd MH. The past, present and future of anti ‑ malarial medicines. Malar J. 2019;18:1–21.
   PubMed Web of Science ®Google Scholar
• South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366(9487):717–725.
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Fanello CI, Hendriksen ICE, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647–1657.
   PubMed Web of Science ®Google Scholar
• Wilson DW, Langer C, Goodman CD, et al. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob Agents Chemother. 2013;57(3):1455–1467.
   PubMed Web of Science ®Google Scholar
• Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77(6 Suppl):181–192.
   PubMed Web of Science ®Google Scholar
• Wamae K, Okanda D, Ndwiga L, et al. No evidence of Plasmodium falciparum K13 artemisisnin resistance-confering mutations over a 24-year analysis in coastal Kenya but a near complete reversion to chloroquine-sensitive parasites. Antimicrob Agents Chemother. 2019;63(12):e01067–19.
   Web of Science ®Google Scholar
• Rakuomi V, Okalebo F, Ndwigah S, et al. Cost effectiveness of pre ‑ referral antimalarial treatment in severe malaria among children in sub ‑ Saharan Africa. Cost Eff Resour Alloc. 2017;14:1–11.
   Google Scholar
• Gomes MF, Faiz MA, Gyapong JO, et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet. 373(9663): 557–566. 2009.
   PubMed Web of Science ®Google Scholar
• Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17(10):1217–1220.
   PubMed Web of Science ®Google Scholar
• Birgersson S, Toi PV, Truong NT, et al. Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers. Malaria J. 2016;15:90.
   PubMed Web of Science ®Google Scholar
• Guo Z. Artemisinin anti-malarial drugs in China. Acta Pharm Sin B. 2016;6(2):115–124.
   PubMed Web of Science ®Google Scholar
• Udomsangpetch R, Pipitaporn B, Krishna S, et al. Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum. J Infect Dis. 1996;173(3):691–698.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan AM, Kumar N. Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species. Antimicrob Agents Chemother. 2015;59(1):317–325.
   PubMed Web of Science ®Google Scholar
• Bridford JL, Xie SC, Cobbold SA, et al. Artesmisinins kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun. 2018;9(1):3801.
   PubMed Web of Science ®Google Scholar
• Klonis N, Creek DJ, Tilley L. Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins. Curr Opin Microbiol. 2013;16(6):722–727.
   PubMed Web of Science ®Google Scholar
• Roussel C, Caumes E, Thellier M, et al. Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications. J Travel Med. 2017;24(2):1–9.
   Web of Science ®Google Scholar
• Barradell LB, Artesunate FA. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs. 1995;50(4):714–741.
   PubMed Web of Science ®Google Scholar
• Morris CA, Duparc S, Borghini-Fuhrer I, et al., Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J. 10(1): 263. 2011.
   PubMed Web of Science ®Google Scholar
• Davis TME, Phuong HL, Ilett KF, et al. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother. 2001;45(1):181–186.
   PubMed Web of Science ®Google Scholar
• Purohit TJ, Hanning SM, Wu Z. Advances in rectal drug delivery systems. Pharm Dev Technol. 2018;23(10):942–952.
   PubMed Web of Science ®Google Scholar
• Jannin V, Lemagnen G, Gueroult P, et al. Rectal route in the 21st Century to treat children. Adv Drug Deliv Rev. 2014;73:34–49.
   PubMed Web of Science ®Google Scholar
• Persaud S, Eid S, Swiderski, et al. Preparations of rectal suppositories containing artesunate. Pharmaceutics. 2020;12(3):222.
   Web of Science ®Google Scholar
• Westman L, Kamanda S, Hellgren U, et al. Rectal administration of chloroquine for treatment of children with malaria. Trans Royal Soc Trop Med Hyg. 1994;88(4):446.
   PubMed Web of Science ®Google Scholar
• Achan J, Byarugaba J, Barennes H, et al. Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial. Clin Inf Dis. 2007;45(11):1446–1452.
   PubMed Web of Science ®Google Scholar
• Karunajeeva HA, Manning L, Mueller I, et al. Rectal administration of artemisinin derivatives for the treatment of malaria. BMC Inf Dis. 2007;297(21):2381–2390.
   Google Scholar
• Krishna S, Planche T, Agbenyega T, et al. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother. 2001;45(2):509–516.
   PubMed Web of Science ®Google Scholar
• Severemalaria.org [internet]. [ cited 2019 Oct 24]. Available from: https://www.severemalaria.org/resources/rectal-artesunate-landscaping-assessment-report.
   Google Scholar
• Li GQ, Guo XB, Jian HX, et al. Observation on the efficacy of qinghaosu suppository in 100 cases of falciparum malaria. J Tradit Chin Med. 1985;5(3):159–161.
   PubMedGoogle Scholar
• Sabchareon A, Attanath P, Chanthavanich P, et al. Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria. Am J Trop Med Hyg. 1998;58(1):11–16.
   PubMed Web of Science ®Google Scholar
• Halpaap B, Ndjave M, Paris M, et al. Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories. Am J Trop Med Hyg. 1998;58(3):365–368.
   PubMed Web of Science ®Google Scholar
• Looareesuwan S, Wilairatana P, Vanijanonta S, et al. Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria. Ann Trop Med Parasitol. 1995;89(5):469–475.
   PubMed Web of Science ®Google Scholar
• Karunajeewa HA, Ilett KF, Dufall K, et al. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria. Antimicrob Agents Chemother. 2004;48(8):2966–2972.
   PubMed Web of Science ®Google Scholar
• Benakisl A, Binh TQ, Keundjian A. Pharmacokinetics/Pharmacodynamics findings after repeated administration of artesunate thermostable suppositories (RECTOCAPS) in vietnamese patients with uncomplicated malaria. Eur J Drug Metab Pharmacokinet. 2006;31(1):41–45.
   PubMed Web of Science ®Google Scholar
• Simpson JA, Agbenyega T, Barnes KI, et al. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. Plos Med. 2006;3(11):e444.
   PubMed Web of Science ®Google Scholar
• Barnes KI, Mwenechanya J, Tembo M, et al. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet. 2004;363:1598–1605.
   PubMed Web of Science ®Google Scholar
• Alecrim MGC, Carvalho LM, Fernandes MC, et al. Malaria treatment with artesunate (retocaps®) in children of the Brazilian Amazon. Rev Soc Bras Med Trop. 2000;33(22):163–168.
   PubMedGoogle Scholar
• Sirivichayakul C, Sabchareon A, Pengsaa K, et al. Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria. Ann Trop Paedriatr. 2007;27(1):17–24.
   PubMed Web of Science ®Google Scholar
• Sam-wobo SO, Agbeyangi OA, Ekpo UF, et al. Rectal artesunates, their utilization, and parental perception in the management of malaria in children from Abeokuta, Southwestern Nigeria. Vector Borne Zoonotic Dis. 2012;12(2):151–155.
   PubMed Web of Science ®Google Scholar
• Gomes M, Ribeiro I, Warsame M, et al. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies. BMC Infect Dis. 2008;13:1–13.
   Google Scholar
• Karunajeewa HA, Kemiki A, Alpers MP, et al. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea. Pediatr Infect Dis J. 2003;22(3):251–255.
   PubMed Web of Science ®Google Scholar
• Gomez EAL, Jurado MH, Cambon N. Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children. Acta Trop. 2003;89(1):47–53.
   PubMed Web of Science ®Google Scholar
• Karunajeewa HA, Reeder J, Lorry K, et al. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea. Antimicrob Agents Chemother. 2006;50(3):968–974.
   PubMed Web of Science ®Google Scholar
• Awad MI, Alkadru AM, Behrens RH. Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan. Am J Trop Med Hyg. 2003;68(2):153–158.
   PubMed Web of Science ®Google Scholar
• Looareesuwan S1, Wilairatana P, Molunto W, et al. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. Am J Trop Med Hyg. 1997;57(3):348–353.
   PubMed Web of Science ®Google Scholar
• Hinton RL, Auwun A, Pongua G, et al. Caregivers` acceptance of using artesunatesuppositories for treating childhood malaria in Papua New Guinea. Am J Trop Med Hyg. 2007;76(4):634–640.
   PubMed Web of Science ®Google Scholar
• Okebe J, Eisenhut M. Pre-referral rectal artesunate for severe malaria. Cochrane Databasee Syst Ver. 2014;29(5):CD009964.
   Google Scholar
• World Health Organization [Internet]. [ cited 2020 Jan 21] Available from: https://www.who.int/tdr/news/2014/malaria-treatment/en.
   Google Scholar
• Hirji KF, Premji ZG. Pre-referral rectal artesunate in severe malaria: flawed trial. Trials. 2011;12:188.
   PubMed Web of Science ®Google Scholar
• Kaona FAD, Tuba M. A qualitative study to identify community structures for management of severe malaria: a basis for introducing rectal artesunate in the under five years children in Nakonde District of Zambia. BMC Public Health. 2005;5(10):1–10.
   PubMed Web of Science ®Google Scholar
• Vermeersch A, Libaud-Moal A, Rodrigues A, et al. Introducing the concept of a new pre-referral treatment for severely ill febrile children at community level: a sociological approach in Guinea Bissau. Malar J. 2014;13(50):1–10.
   PubMed Web of Science ®Google Scholar
• Phiri TB, Khangamwa BNK, Bauleni A, et al. Feasibility, acceptability and impact of integrating malaria rapid diagnostic tests and pre ‑ referral rectal artesunate into the integrated community case management programme. Malar J. 2016;15:177.
   PubMed Web of Science ®Google Scholar
• Siribié M, Ajayi IO, Nsungwa-Sabiiti J, et al. Compliance with referral advice after treatment with prereferral rectal artesunate: a study in 3 sub-saharan African countries. Clin Infect Dis. 2016;63(5):S283–89.
   PubMed Web of Science ®Google Scholar
• Simba DO, Warsame M, Kimbute O, et al. Factors influencing adherence to referral advice following pre-referral treatment with artesunate suppositories in children in rural Tanzania. Trop Med Int Health. 2009;14(7):775–783.
   PubMed Web of Science ®Google Scholar
• Simba DO, Kakoko DC, Warsame M, et al. Understanding caretakers’ dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunate. Malar J. 2010;9(123):1–9.
   PubMed Web of Science ®Google Scholar
• Strachan CE, Nuwa A, Muhangi D, et al. Community understanding of the concept of pre-referral treatment and how this impacts on referral related decision-making following the provision of rectal artesunate: a qualitative study in western Uganda. BMC Health Serv Res. 2018;18:1–12.
   PubMed Web of Science ®Google Scholar
• Warsame G, Gyapong, M. Mpeka, B, et al. Pre-referral rectal artesunate treatment by community-based treatment providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): a cluster-randomized trial. Clin Infect Dis. 2016;63(5):312–321.
   Web of Science ®Google Scholar
• Medicines for Malaria Veenture [Internet]. [ cited 2020 Jan 21]. Available from: https://www.mmv.org/access/tool-kits/rectal-artesunate-tool-kit.
   Google Scholar
• Tozan Y, Klein EY, Darley S, et al. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis. Lancet. 2010;376(9756):1910–1915.
   PubMed Web of Science ®Google Scholar